Updated: March 12, 2026
Retre-Gel Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Overview
Retre-Gel (benzocaine) is generally safe for short-term use, but it can cause serious reactions including methemoglobinemia. Know the signs before you use it.
Is Retre-Gel in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Retre-Gel near you.
Retre-Gel contains 20% benzocaine, a topical local anesthetic used to numb oral tissue before dental procedures and to relieve minor mouth pain. For most people, it works quickly and causes only mild or no side effects. However, benzocaine carries a serious safety warning from the FDA regarding a rare but potentially fatal condition called methemoglobinemia. This guide explains what side effects to expect, which warning signs require immediate medical attention, and who should avoid benzocaine entirely.
Common Side Effects of Retre-Gel
Most people who use Retre-Gel experience minimal side effects. The most common reactions are local and mild:
Mild stinging or burning at the site of application — this is normal and usually passes within seconds to a minute.
Temporary numbness extending slightly beyond the application area — expected and usually brief.
Redness, mild swelling, or irritation at the application site — more common with repeated use.
Skin tenderness or itching — especially in people with sensitive skin or mild PABA sensitivity.
These side effects do not typically require treatment and resolve on their own. If any persist longer than a few hours, contact your healthcare provider.
Check live stock now.
The Most Serious Risk: Methemoglobinemia
Methemoglobinemia is a rare but serious condition in which the blood cannot carry enough oxygen. The FDA has documented over 400 cases of benzocaine-associated methemoglobinemia since 1971, with more than 75% involving life-threatening or serious outcomes. This can occur even with small amounts of benzocaine and even if the product has been used before without problems.
Signs and symptoms of methemoglobinemia typically appear within minutes to 2 hours after benzocaine use. Call 911 immediately if you notice:
Pale, gray, or blue-colored skin, lips, or nail beds
Shortness of breath or difficulty breathing
Confusion or altered mental status
Headache, lightheadedness, or dizziness
Unusually fast heartbeat (tachycardia)
Extreme fatigue or weakness
Treatment for severe methemoglobinemia requires IV methylene blue administered in an emergency setting. Do not wait — call 911 immediately if any of these symptoms appear.
Who Is at Highest Risk for Serious Side Effects?
Certain groups face a significantly higher risk of serious adverse events from benzocaine:
Infants and children under 2 years — The FDA has contraindicated benzocaine topical use in this age group. Do not use Retre-Gel for infant teething.
Elderly patients — Age-related changes in red blood cell function increase susceptibility.
Patients with G6PD deficiency, hemoglobin-M disease, or NADH-methemoglobin reductase deficiency — These inherited conditions impair the body's ability to reduce methemoglobin levels.
Patients with heart disease, asthma, COPD, or emphysema — Reduced oxygen-carrying capacity makes methemoglobinemia more dangerous.
Smokers — Smoking reduces baseline oxygen saturation and increases risk.
Allergic Reactions to Benzocaine
Benzocaine is an ester-type local anesthetic derived from para-aminobenzoic acid (PABA). People with known PABA sensitivity or allergies to other ester-type anesthetics (such as procaine or tetracaine) may experience:
Contact dermatitis (rash, redness, blistering at application site)
Hives or widespread itching
Anaphylaxis (rare but possible — swelling of throat, difficulty breathing, drop in blood pressure)
If you have had a reaction to a dental anesthetic or a topical pain reliever in the past, tell your provider before using Retre-Gel. Patients who are PABA-allergic can usually tolerate amide-type anesthetics like lidocaine.
When to Call Your Doctor vs. Call 911
Call 911 immediately: Blue or gray lips/nails/skin; difficulty breathing; severe confusion; loss of consciousness.
Call your doctor or pharmacist: Persistent rash or irritation; symptoms that don't improve within 7 days; sore throat with fever, headache, or swollen glands.
Normal — no action needed: Brief stinging at application, temporary numbness, mild tingling.
For a full list of drug interactions to be aware of when using Retre-Gel, see our guide on Retre-Gel drug interactions. For general information about this medication, see what is Retre-Gel and how is it used.
Frequently Asked Questions
Yes. The most serious risk is methemoglobinemia, a rare condition in which blood cannot carry enough oxygen. Symptoms appear within minutes to 2 hours and include blue/gray skin, shortness of breath, confusion, and fast heartbeat. This is a medical emergency — call 911 immediately if these symptoms occur.
Retre-Gel is contraindicated in infants and children under 2 years old due to the risk of methemoglobinemia. For children 2 years and older, it may be used as directed, but should not be applied more than 3-4 times daily. Do not use Retre-Gel for infant teething.
Benzocaine typically produces a numbing or tingling sensation at the application site within 30-60 seconds. The area will feel numb or have reduced sensation, which is the intended effect. A brief initial stinging or burning is normal and should pass quickly.
Yes. Retre-Gel (benzocaine) is derived from PABA (para-aminobenzoic acid). People who are allergic to PABA, sulfonamides, or other ester-type anesthetics may experience allergic reactions ranging from contact dermatitis to anaphylaxis. Tell your dentist or doctor about any prior anesthetic allergies before using benzocaine.
The numbing effect of 20% benzocaine topical gel typically lasts 15-30 minutes after application. In some formulations (like BeeGentle), the release may be extended to 20-30 minutes due to a film-forming base. Effects gradually wear off as the drug dissipates from the application site.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Retre-Gel also looked for:
More about Retre-Gel
39,483 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





